Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10Q


During the three and six months ended November 30, 2016, PDS entered into a licensing agreement with a third party, pursuant to which PDS received proceeds of $3,000,000.

 

https://www.sec.gov/Archives/edgar/data/836564/000168316817000100/patriot_10q-113016.htm

 

 

Share
New Message
Please login to post a reply